Search - tctmd.com

Displaying 301 - 320 of 629

Sort: Relevancy | Date

News Opinion CV Team Dispatch

August 2022 News Roundup

L.A. McKeown

August 01, 2022

News Daily News

CMR Could Refine Early Management Decisions in Aortic Regurgitation

L.A. McKeown

July 27, 2022

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Shelley Wood

July 25, 2022

News Daily News

Myocarditis Phenotype Is a Key Predictor of Outcomes in COVID-19

Michael O'Riordan

July 20, 2022

News Daily News

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Michael O'Riordan

July 19, 2022

News Daily News

US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution?

Shelley Wood

July 15, 2022

News Daily News

‘It’s All Cuts’: Cardiologists React to the 2023 CMS Proposed Rule

Yael L. Maxwell

July 15, 2022

News Daily News

Shock in Peripartum Cardiomyopathy Especially Risky in Black, Hispanic Patients

Caitlin E. Cox

July 13, 2022

News Opinion CV Team Dispatch

July 2022 News Roundup

L.A. McKeown

July 01, 2022

News Opinion Off Script

To Save a Dying Mother

Kathryn J. Lindley, MD

June 28, 2022

News Daily News

Myocarditis Risk Varies by COVID-19 Vaccine Type, Dosing Interval

Todd Neale

June 28, 2022

News Daily News

COVID-19 Vaccination Tied to Better Outcomes in HF Patients

Todd Neale

June 09, 2022

News Daily News

Heart Failure Risks of Smoking Can Linger for Decades

L.A. McKeown

June 07, 2022

News Daily News

COVID-19 Had Broad Global Effects on CV Care, Review Affirms

Todd Neale

June 02, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2022

Shelley Wood

June 01, 2022

News Opinion CV Team Dispatch

June 2022 News Roundup

L.A. McKeown

June 01, 2022

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

Shelley Wood

May 26, 2022

News Conference News ESC Heart Failure 2022

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

Shelley Wood

May 25, 2022

News Conference News ESC Heart Failure 2022

Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients

Shelley Wood

May 23, 2022

News Conference News ESC Heart Failure 2022

Dapagliflozin Boosts Health Status Across LVEF Range

Shelley Wood

May 23, 2022

Advertisement

August 2022 News Roundup

CMR Could Refine Early Management Decisions in Aortic Regurgitation

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Myocarditis Phenotype Is a Key Predictor of Outcomes in COVID-19

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution?

‘It’s All Cuts’: Cardiologists React to the 2023 CMS Proposed Rule

Shock in Peripartum Cardiomyopathy Especially Risky in Black, Hispanic Patients

July 2022 News Roundup

To Save a Dying Mother

Myocarditis Risk Varies by COVID-19 Vaccine Type, Dosing Interval

COVID-19 Vaccination Tied to Better Outcomes in HF Patients

Heart Failure Risks of Smoking Can Linger for Decades

COVID-19 Had Broad Global Effects on CV Care, Review Affirms

TCTMD’s Top 10 Most Popular Stories for May 2022

June 2022 News Roundup

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients

Dapagliflozin Boosts Health Status Across LVEF Range

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content